Home

Ra Capital Management reported a 14.3% stake in Sionna Therapeutics SION · 6,476,193 sh · amendment

Trade details

Type
5% stake report
Report
13D · amendment
Stake
14.3%
Last report
22.6% · filed 25/11/07
Shares held
6,476,193 sh
Class
Common Stock, $0.001 par value per share
Event date
26/09/17
Filed
26/09/21

14.3% stake · −8.3pp from the last report

Stake
14.3%
Last report
22.6%
Since last report
−8.3pp

Sionna Therapeutics trades, last 26 weeks

What else happened in Sionna Therapeutics around then

Filed or reported within 30 days of the trade day · 08/18~10/17

Ra Capital Management's other 5% stake reports

  • Ra Capital Management

    5% stakeCorbus Pharmaceuticals Holdings

    9.9% stake

    Filed 09/30

  • Ra Capital Management

    5% stakeBetterLife Pharma

    9% stake

    Filed 09/22

  • Ra Capital Management

    5% stakeTyra Biosciences

    19.9% stake

    Filed 09/17

  • Ra Capital Management

    5% stakeJatt III Acquisition

    5.1% stake

    Filed 09/03

  • Ra Capital Management

    5% stakeLatigo Biotherapeutics

    8.4% stake

    Filed 08/17

Ra Capital Management reported a 14.3% stake in Sionna Therapeutics SION · 6,476,193 sh · amendment | Whalegun